【结 构 式】 |
【分子编号】68852 【品名】tert-butyl 2(S)-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate 【CA登记号】 |
【 分 子 式 】C18H22BrN3O2 【 分 子 量 】392.296 【元素组成】C 55.11% H 5.65% Br 20.37% N 10.71% O 8.16% |
合成路线1
该中间体在本合成路线中的序号:(VIII)Daclatasvir can be prepared by two alternative methods:
Bromination of 4,4’-diacetylbiphenyl (I) with Br2 in CH2Cl2 generates 4,4’-bis(bromoacetyl)biphenyl (II), which is then condensed with NBoc-L-proline (III) in the presence of DIEA in acetonitrile to give the diester (IV). Subsequent cyclization of the keto ester (IV) with NH4OAc in toluene at 95-100 °C affords the bis(imidazole) precursor (V) . In an alternative method, coupling of N-Boc-L-proline (III) with 2-amino-4’-bromoacetophenone (VI) by means of HATU and DIEA in DMF provides the keto amide (VII), which undergoes cyclization to the imidazolyl-pyrrolidine (VIII) upon heating to 140 °C with NH4OAc in xylenes in a sealed tube. Treatment of the aryl bromide (VIII) with bis(pinacolato)diboron in the presence of Pd(PPh3)4 and KOAc in dioxane at 80 °C gives rise to the boronate ester (IX). Then, Suzuki coupling between bromide (VIII) and boronate (IX) using Pd(PPh3)4 and NaHCO3 in DME/H2O at 80 °C also affords the bis(imidazolyl)biphenyl precursor (V) . Deprotection of compound (V) with either TFA in CH2Cl2 or HCl in MeOH or i-PrOH/H2O at 50 °C provides the N-unsubstituted-bis(pyrrolidine) compound (X), which is then acylated with N-(methoxycarbonyl)-L-valine (XI) by means of EDC, HOBt·H2O and DIEA in acetonitrile, followed by treatment with HCl in EtOH .
【1】 Bachand, C., Belema, M., Deon, D.H. et al. (Bristol-Myers Squibb Co.). Hepatitis C virus inhibitors. EP 2049522, JP 201050013, WO 2008021927. |
【2】 Pack, S.K., Geng, P., Smith, M.J., Hamm, J. (Bristol-Myers Squibb Co.). Process for synthesizing compounds useful for treating hepatitis C. CN 101778841, EP 2178863, JP 2010535784, US 2009043107, US 7728027, WO 2009020825. |
【3】 Kim, S., Gao, Q., Yang, F. (Bristol-Myers Squibb Co.). Crystalline form of methyl ((1S)-1-(((2S)-2-(5-(4’-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt. CN 101778840, EP 2183244, JP 2010535785, US 2009041716, WO 2009020828. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 68845 | 4,4'-Diacetylbiphenyl;1,1'-([1,1'-biphenyl]-4,4'-diyl)diethanone;1-(4'-Acetyl[1,1'-biphenyl]-4-yl)ethan-1-one | 787-69-9 | C16H14O2 | 详情 | 详情 |
(II) | 68846 | 4,4’-bis(bromoacetyl)biphenyl;4,4'-Bis(2-bromoacetyl)biphenyl;1,1'-([1,1'-biphenyl]-4,4'-diyl)bis(2-bromoethanone);1,1'-(1,1'-Biphenyl)-4,4'-diylbis(2-bromoethan-1-one);2-Bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone;4,4'-Bis(2-bromoacetyl)biphenyl | 4072-67-7 | C16H12Br2O2 | 详情 | 详情 |
(III) | 16734 | (2S)-1-(tert-butoxycarbonyl)tetrahydro-1H-pyrrole-2-carboxylic acid; N-alpha-t-BOC-L-proline; (2S)-1-(tert-butoxycarbonyl)-2-pyrrolidinecarboxylic acid | C10H17NO4 | 详情 | 详情 | |
(IV) | 68849 | C36H44N2O10 | 详情 | 详情 | ||
(V) | 68848 | C36H44N6O4 | 详情 | 详情 | ||
(VI) | 68851 | 2-amino-1-(4-bromophenyl)ethanone hydrochloride | C8H8BrNO.HCl | 详情 | 详情 | |
(VII) | 68850 | tert-butyl 2(S)-((2-(4-bromophenyl)-2-oxoethyl)carbamoyl)pyrrolidine-1-carboxylate | C18H23BrN2O4 | 详情 | 详情 | |
(VIII) | 68852 | tert-butyl 2(S)-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate | C18H22BrN3O2 | 详情 | 详情 | |
(IX) | 68853 | tert-butyl 2(S)-(5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate | C24H34BN3O4 | 详情 | 详情 | |
(X) | 68847 | (S)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | C22H32N6.4HCl | 详情 | 详情 | |
(XI) | 68854 | (S)-2-((methoxycarbonyl)amino)-3-methylbutanoic acid | C7H13NO4 | 详情 | 详情 |